Benefits of Early Systemic Corticosteroid in Clinical Deterioration of Post-COVID-19 Interstitial Lung Disease

Tuberculosis and Respiratory Diseases 2022³â 85±Ç 4È£ p.358 ~ p.360

¾ÈÅÂÁØ(An Tai-Joon) - Catholic University College of Medicine Yeouido St. Mary¡¯s Hospital Department of Internal Medicine
ÀÌ¿¹Áø(Lee Ye-Jin) - Seoul National University Hospital Department of Internal Medicine
¹ÚÁöÀº(Park Ji-Eun) - Ajou University School of Medicine Department of Pulmonary and Critical Care Medicine
ÀÌÀÀ±¸(Lee Eung-Gu) - Catholic University College of Medicine Bucheon St. Mary¡¯s Hospital Department of Internal Medicine
±èÀ¯¸²(Kim You-Lim) - Konkuk University School of Medicine Konkuk University Medical Center Department of Internal Medicine
°­¼ºÀ±(Kang Sung-Yoon) - Gachon University Gil Medical Center Department of Internal Medicine
ÁÖÇö¼ö(Joo Hyon-Soo) - Catholic University College of Medicine Uijeongbu St. Mary¡¯s Hospital Department of Internal Medicine
ÃÖÁØ¿µ(Choi Joon-Young) - Catholic University College of Medicine Incheon St. Mary¡¯s Hospital Department of Internal Medicine

Abstract

Å°¿öµå

KMID : 1044520220850040358 doi.org/10.4046/trd.2022.0072
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
This article recommend the administration of systemic corticosteroids in acute exacerbation patients who have overcome acute COVID-19 infection.
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
doi.org/10.4046/trd.2022.0072
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå